ARADIGM CORP Contracts & Agreements

78 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
AMENDED AND RESTATED CHANGE OF CONTROL AGREEMENT
Change of Control Agreements
ARADIGM CORP
Pharmaceuticals
CA
2011
Bidding Procedures
ARADIGM CORP
Pharmaceuticals
2020
Asset Purchase Agreement dated February 18, 2020, between Aradigm Corporation and Grifols, S.A
Purchase Agreements
ARADIGM CORP
2020
Form of 9.0% Convertible Senior Notes due 2021
Note Agreements
ARADIGM CORP
Pharmaceuticals
CA
2018
Change of Control Agreement between Aradigm Corporation and John Siebert, dated as of October 31, 2018
Change of Control Agreements
ARADIGM CORP
2018
Senior Note Purchase Agreement, dated October 25, 2018, by and between Aradigm Corporation and Grifols Worldwide Operations Ltd
Note Agreements
ARADIGM CORP
Pharmaceuticals
NY
2018
Form of 9.0% Senior Promissory Note due 2021
Note Agreements
ARADIGM CORP
Pharmaceuticals
NY
2018
Aradigm Corporation Employee Stock Purchase Plan, as amended
Stock Agreements
ARADIGM CORP
2018
Employment Agreement between Aradigm Corporation and Juergen Froehlich, dated May 31, 2018
Employment Agreements
ARADIGM CORP
2018
Change of Control Agreement between Aradigm Corporation and Juergen Froehlich, dated May 31, 2018
Change of Control Agreements
ARADIGM CORP
2018
Form of 9.0% Convertible Senior Notes due 2021
Note Agreements
ARADIGM CORP
Pharmaceuticals
NY
2018
Supplemental Indenture, dated as of April 18, 2018, between the Company and U.S Bank National Association, as trustee
Indenture Agreements
ARADIGM CORP
2018
Senior Note Purchase Agreement, dated April 13, 2018, among Aradigm Corporation, Grifols Worldwide Operations Ltd., 21 April Fund, Ltd., 21 April Fund, LP and First Eagle Value in...
Note Agreements
ARADIGM CORP
2018
Form of 9.0% Senior Promissory Note due 2021
Note Agreements
ARADIGM CORP
2018
Employment Agreement between Aradigm Corporation and John Siebert, March 22, 2018
Employment Agreements
ARADIGM CORP
2018
SECURITIES PURCHASE AGREEMENT by and between ARADIGMCORPORATION and THE PURCHASERS NAMED ON SCHEDULES A and B HERETO Dated as of April 21, 2016 Table of Contents
Purchase Agreements
ARADIGM CORP
Pharmaceuticals
CA
2016
ARADIGM CORPORATION AND U.S. BANK NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of April 25, 2016 9.0% Convertible Senior Notes due 2021 TABLE OF CONTENTS
Indenture Agreements
ARADIGM CORP
2016
ESCROW AGREEMENT
Escrow Agreements
ARADIGM CORP
2016
AMENDMENT TO GOVERNANCEAGREEMENT
ARADIGM CORP
Pharmaceuticals
2016
AMENDMENT TO THE STOCK OPTION AGREEMENT
Stock Agreements
ARADIGM CORP
Pharmaceuticals
2016
SUPPLY AGREEMENT
Supply Agreements
ARADIGM CORP
Pharmaceuticals
2016
ARADIGM CORPORATION STOCK OPTION AGREEMENT
Stock Agreements
ARADIGM CORP
2014
ASSIGNMENT, ASSUMPTION, WAIVER AND CONSENT February 28, 2014
Waiver Agreements
ARADIGM CORP
Pharmaceuticals
2014
CHANGE OF CONTROL AGREEMENT
Change of Control Agreements
ARADIGM CORP
2014
ATTACHMENT A
ARADIGM CORP
2014
CLINICAL SUPPLY AND COMMERCIAL MANUFACTURING SERVICES AGREEMENT
Supply Agreements
ARADIGM CORP
2013
STOCK PURCHASE AGREEMENT by and between ARADIGM CORPORATION and GRIFOLS, S.A. Dated as of May 20, 2013 TABLE OF CONTENTS
Stock Agreements
ARADIGM CORP
2013
LICENSE AND COLLABORATION AGREEMENT
Collaboration Agreements
ARADIGM CORP
Pharmaceuticals
NY
2013
Aradigm-Grifols Option Terms for License, Development andCommercialization Agreement for Use of AERx Inhaler with Alpha-1 Antitrypsin Background
License Agreements
ARADIGM CORP
2013
GOVERNANCE AGREEMENT by and between ARADIGM CORPORATION and GRIFOLS, S.A. Dated as of [ ], 2013 TABLE OF CONTENTS
ARADIGM CORP
2013
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
ARADIGM CORP
Pharmaceuticals
NY
2013
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
ARADIGM CORP
2013
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
ARADIGM CORP
Pharmaceuticals
NY
2012
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
ARADIGM CORP
2012
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
ARADIGM CORP
Pharmaceuticals
NY
2011
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
ARADIGM CORP
Pharmaceuticals
NY
2011
ARADIGM CORPORATION EXECUTIVE OFFICER SEVERANCE BENEFIT PLAN
Severance Agreements
ARADIGM CORP
2011
Signature Page to Amended and Restated Change of Control Agreement
Change of Control Agreements
ARADIGM CORP
2011
ARADIGM CORPORATION
ARADIGM CORP
Pharmaceuticals
CA
2011
FINANCIAL STATEMENTS
ARADIGM CORP
Pharmaceuticals
CA
2009
FINANCIAL STATEMENTS
ARADIGM CORP
Pharmaceuticals
CA
2009
FINANCIAL STATEMENTS
ARADIGM CORP
2009
FINANCIAL STATEMENTS
ARADIGM CORP
2009
ARADIGM CORPORATION Employee Stock Purchase Plan Adopted April 16, 1996 Approved by the Shareholders on June 5, 1996 Amended by the Board of Directors on April 7, 1998 Approved by...
Stock Agreements
ARADIGM CORP
Pharmaceuticals
2009
4,000,000 Shares
ARADIGM CORP
Pharmaceuticals
NY
2009
40,663,071 Shares
ARADIGM CORP
2009
ARADIGM CORPORATION EXECUTIVE OFFICER SEVERANCE BENEFIT PLAN
Severance Agreements
ARADIGM CORP
2009
CHANGE OF CONTROL AGREEMENT
Change of Control Agreements
ARADIGM CORP
2009
ARADIGM CORPORATION CONSULTING AGREEMENT FOR INDEPENDENT CONTRACTORS
Consulting Agreements
ARADIGM CORP
Pharmaceuticals
CA
2008
Aradigm Corporation International Scientific Advisory Agreement
Advisory Agreements
ARADIGM CORP
Pharmaceuticals
2008
Current assets
ARADIGM CORP
Pharmaceuticals
CA
2008
Current assets
ARADIGM CORP
2008
Current assets
ARADIGM CORP
2008
Current assets
ARADIGM CORP
2007
Current assets
ARADIGM CORP
2007
MASTER DEVELOPMENT AND MANUFACTURING AGREEMENT Clinical Products
Development Agreements
ARADIGM CORP
2007
SUBLEASE
Lease Agreements
ARADIGM CORP
2007
Consulting Agreement effective as of July 2, 2007 by and between the Company and Norman Halleen
Consulting Agreements
ARADIGM CORP
2007
AMENDMENT NO. 3 TO RIGHTS AGREEMENT BETWEEN ARADIGM CORPORATION AND COMPUTERSHARE TRUST COMPANY, N.A.
ARADIGM CORP
2007
We intend to develop a proprietary portfolio of respiratory disease therapies, where we apply our delivery and formulation technologies to existing drugs to provide a superior...
ARADIGM CORP
2007
We intend to develop a proprietary portfolio of respiratory disease therapies, where we apply our delivery and formulation technologies to existing drugs to provide a superior...
ARADIGM CORP
2007
We intend to develop a proprietary portfolio of respiratory disease therapies, where we apply our delivery and formulation technologies to existing drugs to provide a superior...
ARADIGM CORP
2006
We intend to develop a proprietary portfolio of respiratory disease therapies, where we apply our delivery and formulation technologies to existing drugs to provide a superior...
ARADIGM CORP
2006
We intend to develop a proprietary portfolio of respiratory disease therapies, where we apply our delivery and formulation technologies to existing drugs to provide a superior...
ARADIGM CORP
2006
We intend to develop a proprietary portfolio of respiratory disease therapies, where we apply our delivery and formulation technologies to existing drugs to provide a superior...
ARADIGM CORP
2006
We intend to develop a proprietary portfolio of respiratory disease therapies, where we apply our delivery and formulation technologies to existing drugs to provide a superior...
ARADIGM CORP
2006
We intend to develop a proprietary portfolio of respiratory disease therapies, where we apply our delivery and formulation technologies to existing drugs to provide a superior...
ARADIGM CORP
2006
Current assets
ARADIGM CORP
2006
Stage of Development
Development Agreements
ARADIGM CORP
2006
Stage of Development
Development Agreements
ARADIGM CORP
2006
Securities Purchase Agreement, dated as of December 17, 2004
Purchase Agreements
ARADIGM CORP
Pharmaceuticals
CA
2004
In thousands, except shares data
ARADIGM CORP
2004
ARADIGM CORPORATION SECURITIES PURCHASE AGREEMENT
Purchase Agreements
ARADIGM CORP
2003
ARADIGM CORPORATION SECURITIES PURCHASE AGREEMENT NOVEMBER 7, 2003 ARADIGM CORPORATION SECURITIES PURCHASE AGREEMENT
Purchase Agreements
ARADIGM CORP
2003
EXHBIIT 10.15A
ARADIGM CORP
2002
EXHIBIT 10.15B
ARADIGM CORP
2002
Novo Nordisk A/S, the world leader in insulin products, for the needle-free delivery of insulin for diabetes; and
ARADIGM CORP
2002
Novo Nordisk A/S, the world leader in insulin products, for the needle-free delivery of insulin for diabetes; and
ARADIGM CORP
2002